News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
356,682 Results
Type
Article (20679)
Company Profile (141)
Press Release (335852)
Multimedia
Podcasts (76)
Webinars (13)
Section
Business (108189)
Career Advice (732)
Deals (25287)
Drug Delivery (86)
Drug Development (43286)
Employer Resources (66)
FDA (8208)
Job Trends (8256)
News (189400)
Policy (17625)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (848)
Accelerated approval (16)
Adcomms (10)
Allergies (82)
Alliances (28485)
ALS (88)
Alzheimer's disease (669)
Antibody-drug conjugate (ADC) (173)
Approvals (8470)
Artificial intelligence (350)
Autoimmune disease (79)
Automation (21)
Bankruptcy (194)
Best Places to Work (6030)
BIOSECURE Act (10)
Biosimilars (136)
Biotechnology (67)
Bladder cancer (52)
Brain cancer (42)
Breast cancer (275)
Cancer (2128)
Cardiovascular disease (219)
Career advice (649)
Career pathing (19)
CAR-T (106)
CDC (10)
Cell therapy (295)
Cervical cancer (20)
Clinical research (37742)
Collaboration (1059)
Company closure (1)
Compensation (394)
Complete response letters (40)
COVID-19 (1129)
CRISPR (57)
C-suite (537)
Cystic fibrosis (71)
Data (2837)
Denatured (18)
Depression (72)
Diabetes (216)
Diagnostics (2521)
Digital health (25)
Diversity (4)
Diversity, equity & inclusion (21)
Drug discovery (174)
Drug pricing (129)
Drug shortages (15)
Duchenne muscular dystrophy (101)
Earnings (42862)
Editorial (28)
Employer branding (6)
Employer resources (62)
Events (47055)
Executive appointments (641)
FDA (9863)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (9)
Funding (687)
Gene editing (102)
Generative AI (29)
Gene therapy (275)
GLP-1 (598)
Government (1924)
Grass and pollen (4)
Guidances (254)
Healthcare (6451)
HIV (33)
Huntington's disease (13)
IgA nephropathy (52)
Immunology and inflammation (108)
Immuno-oncology (28)
Indications (72)
Infectious disease (1246)
Inflammatory bowel disease (107)
Inflation Reduction Act (7)
Influenza (49)
Intellectual property (161)
Interviews (110)
IPO (8127)
IRA (39)
Job creations (2479)
Job search strategy (555)
JPM (39)
Kidney cancer (9)
Labor market (35)
Layoffs (304)
Leadership (13)
Legal (4461)
Liver cancer (36)
Longevity (11)
Lung cancer (314)
Lymphoma (193)
Machine learning (22)
Management (21)
Manufacturing (553)
MASH (93)
Medical device (4083)
Medtech (4104)
Mergers & acquisitions (18022)
Metabolic disorders (644)
Multiple sclerosis (77)
NASH (14)
Neurodegenerative disease (145)
Neuropsychiatric disorders (54)
Neuroscience (1295)
Neurotech (1)
NextGen: Class of 2026 (2609)
Non-profit (1259)
Now hiring (20)
Obesity (322)
Opinion (183)
Ovarian cancer (47)
Pain (126)
Pancreatic cancer (84)
Parkinson's disease (126)
Partnered (17)
Patents (306)
Patient recruitment (186)
Peanut (17)
People (34430)
Pharmaceutical (70)
Pharmacy benefit managers (22)
Phase 1 (10100)
Phase 2 (16097)
Phase 3 (14141)
Pipeline (2992)
Policy (156)
Postmarket research (1571)
Preclinical (4198)
Press Release (28)
Prostate cancer (117)
Psychedelics (20)
Radiopharmaceuticals (170)
Rare diseases (492)
Real estate (3249)
Recruiting (25)
Regulatory (13620)
Reports (25)
Research institute (916)
Resumes & cover letters (108)
Rett syndrome (23)
RNA editing (8)
RSV (33)
Schizophrenia (104)
Series A (130)
Series B (84)
Service/supplier (4)
Sickle cell disease (56)
Special edition (13)
Spinal muscular atrophy (96)
Sponsored (17)
Startups (2144)
State (2)
Stomach cancer (7)
Supply chain (63)
Tariffs (72)
The Weekly (56)
Vaccines (411)
Venture capital (46)
Weight loss (209)
Women's health (41)
Worklife (5)
Date
Today (16)
Last 7 days (269)
Last 30 days (1066)
Last 365 days (14962)
2026 (1950)
2025 (15479)
2024 (17245)
2023 (19097)
2022 (26261)
2021 (27155)
2020 (25752)
2019 (21112)
2018 (16702)
2017 (17732)
2016 (16592)
2015 (19402)
2014 (15359)
2013 (13027)
2012 (13921)
2011 (14539)
2010 (13303)
Location
Africa (420)
Alabama (27)
Alaska (2)
Arizona (114)
Arkansas (6)
Asia (25424)
Australia (3412)
California (4640)
Canada (1879)
China (698)
Colorado (203)
Connecticut (219)
Delaware (178)
Europe (52182)
Florida (836)
Georgia (122)
Hawaii (2)
Idaho (22)
Illinois (455)
India (52)
Indiana (331)
Iowa (4)
Japan (319)
Kansas (84)
Kentucky (25)
Louisiana (16)
Maine (12)
Maryland (593)
Massachusetts (3625)
Michigan (101)
Minnesota (215)
Mississippi (1)
Missouri (57)
Montana (13)
Nebraska (9)
Nevada (33)
New Hampshire (24)
New Jersey (1892)
New Mexico (10)
New York (1332)
North Carolina (895)
North Dakota (4)
Northern California (2092)
Ohio (136)
Oklahoma (6)
Oregon (22)
Pennsylvania (1094)
Puerto Rico (17)
Rhode Island (24)
South America (668)
South Carolina (22)
Southern California (1978)
Tennessee (124)
Texas (677)
United States (18326)
Utah (106)
Vermont (1)
Virginia (180)
Washington D.C. (50)
Washington State (362)
West Virginia (3)
Wisconsin (64)
Wyoming (1)
356,682 Results for "arcutis pharmaceuticals acquired by valeant pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa
January 27, 2026
·
5 min read
Press Releases
Arcutis Highlights 2026 Strategic Priorities and Anticipated Milestones
January 12, 2026
·
7 min read
Press Releases
Cycle Pharmaceuticals to Acquire Applied Therapeutics
December 12, 2025
·
10 min read
Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2026
February 6, 2026
·
2 min read
Press Releases
Arcutis to Report Fourth Quarter and Full Year 2025 Financial Results and Present at Upcoming Investor Conference
January 23, 2026
·
3 min read
Press Releases
Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri
December 9, 2025
·
6 min read
Press Releases
Harrow to Acquire Melt Pharmaceuticals
September 29, 2025
·
8 min read
Press Releases
Arcutis to Present at Upcoming November 2025 Investor Conferences
October 28, 2025
·
2 min read
Press Releases
Arcutis Announces Positive Topline Results for INTEGUMENT-INFANT Phase 2 Trial of ZORYVE® (roflumilast) Cream 0.05% in Infants with Mild to Moderate Atopic Dermatitis
February 2, 2026
·
8 min read
Press Releases
Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
December 10, 2025
·
6 min read
1 of 35,669
Next
